Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection

Annals of Pharmacotherapy

Volumn 39, Issue 5, 2005, Pages 949-952

  Quinn, Andrea L ^a   Parada, Jorge P ^a,b,c,d   Belmares, Jaime ^a,c   O'Keefe, J Paul ^a,b,c  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c HINES VA HOSPITAL   (United States)

^d Hines VA Midwest Ctr Hlth Serv P   (United States)

Author keywords

Colistin; Multidrug resistant pseudomonas aeruginosa; Ventriculo peritoneal shunt

Indexed keywords

AMIKACIN; CEFEPIME; COLISTIN; POLYMYXIN B;

AGED; ANAMNESIS; ARTICLE; BACTERIAL MENINGITIS; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; DRUG SENSITIVITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYDROCEPHALUS; INSTRUMENT STERILIZATION; KIDNEY FUNCTION; LEUKOCYTE COUNT; MULTIDRUG RESISTANCE; NEPHROTOXICITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SHUNT INFECTION; SUBARACHNOID HEMORRHAGE;

AGED; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INJECTIONS, SPINAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VENTRICULOPERITONEAL SHUNT;

EID: 17644367858     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E485     Document Type: Article

References (22)

1. Berrouane YF, McNutt LA, Buschelman BJ, Rhomberg PR, Sanford MD, Hollis RJ, et al. Outbreak of Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub. Clin Infect Dis 2000;31:1331-7.
2. Levin AS, Barone AA, Penco J, Santos MV, Marinho IS, Arruda EAG, et al. Intravenous colistin as therapy for nosocomial infection caused by multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999;28:1008-11.
3. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 2002;34:634-40.
4. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001;39:183-90.
5. Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 2001;119(2 suppl):397S-404S.
6. Catchpole CR, Andrews JM, Brenwald N, Wise R. A reassessment of invitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 1997;39:255-60.
7. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 1999;33:960-7. DOI 10.1345/aph.18426
8. Stein A, Raoult D. Colistin: an antimicrobial for the 21st century? (letter). Clin Infect Dis 2002;35:901-2.
9. Horton J, Pankey GA. Polymyxin B, colistin and sodium colistimethate. Med Clin North Am 1982;66:135-42.
10. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Ann Intern Med 1970;72:857-68.
11. Jimenez-Mejias ME, Pichardo-Guerrero C, Marquez-Rivas FJ, Martin-Lozano D, Prados T, Pachon J. Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium. Eur J Clin Microbiol Infect Dis 2000;19:970-1.
12. Jimenez-Mejias ME, Pichardo-Guerrero C, Marquez-Rivas FJ, Martin-Lozano D, Prados T, Pachon J. Cerebrospinal fluid penetration and pharmacokinetic/ pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 2002;21:212-4.
13. Vasen W, Desmery P, Di Martino A. Intrathecal use of colistin (letter). J Clin Microbiol 2000;38:3523.
14. Benifla M, Zucker G, Cohen A, Alkan M. Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E (letter). J Antimicrob Chemother 2004;54(1):290-2.
15. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
16. Package insert. Colistimethate injection. Northport, NY: X-Gen Pharmaceuticals, January 2004.
17. Clifford HE, Stewart GT. Intraventricular administration of a new derivative of polymyxin B in meningitis due to Ps. pyocyanea. Lancet 1961;2:798-9.
18. Segal-Maurer S, Mariano N, Quavi A, Usrban C, Rahal JJ. Successful treatment of ceftazidime-resistant Klebsiella pneumonia ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review. Clin Infect Dis 1999;28:1134-8.
19. Simon C, Lang F, Holtman RS. Successful treatment of Acinetobacter calcoaceticus ventriculitis and development of subsequent chemical meningitis following intraventricular polymyxin B (abstract 207). Presented at: 37th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, November 17-21, 1999.
20. Fernandez-Viladrich P, Corbella X, Corral L, Tubau F, Mateu A. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin Infect Dis 1999;28:916-7.
21. Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbation in adults with cystic fibrosis. Ann Pharmacother 2000;34:1238-42. DOI 10.1345/aph.19370
22. Garancho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garica-Garmendia JL, Bernabeu-Wittel M, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-cilastatin VAP. Clin Infect Dis 2003;36:1111-8.